Saudi Arabia Osteoporosis Drugs Market is Expected to Reach the Value of USD 7,011,317.72 thousand, At a CAGR of 4.62% During the Forecast Period 2022-2029
Saudi Arabia
Osteoporosis Drugs Market By Type (Primary Osteoporosis & Secondary Osteoporosis), Drugs (Bisphosphonates, Monoclonal
Antibodies, Hormone Therapy & Others), Drugs Type (Branded & Generic),
Route of Administration (Injectable, Oral & Others), Gender (Female &
Male), Age Group (Geriatrics, Adults & Pediatrics), End User (Hospitals,
Specialty Clinics, Homecare & Others), Distribution Channel (Direct Tender,
Retail Sales & Others) Industry Trends and Forecasts to 2029.
Get
Your Sample Today: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=saudi-arabia-osteoporosis-drug-market
Data Bridge Market
Research analyses that the Saudi Arabia osteoporosis drugs market will grow at
a CAGR of 2.9% during the forecast period of 2022 to 2029. According to the
International Osteoporosis Foundation (IOF), ‘osteoporosis, which means porous
bone, is a disease in which the quality and density of bone are reduced. As
bones become more fragile and porous, the risk of fracture is greatly
increased. The loss of bone occurs progressively and silently. Often there are
no symptoms until the first fracture occurs.
Saudi Arabia
Osteoporosis Drugs Market Analysis and Insights
The different types
of medications for osteoporosis are
available in the market. The bisphosphonates are usually the first choice for
treatment of osteoporosis. These includes Risedronate (Actonel), a weekly or
monthly pill, Alendronate (Fosamax), a weekly pill, Zoledronic acid (Reclast),
an annual IV infusion and Ibandronate (Boniva), a monthly pill or
quarterly intravenous (IV) infusion.
With age, some of
the bone cells begin to dissolve bone matrix, the process is called resorption,
while new bone cells deposit osteoid, and the process is called formation. This
process is called as remodeling. For people with osteoporosis, bone loss
outpaces the growth of new bone. Bones become brittle, porous and prone to
fracture. Though osteoporosis fractures can occur in other bones also, but he
most commonly osteoporosis fractures occurs at wrist, spine or the hip.
Request Access for Saudi Arabia Osteoporosis
Drugs Market
Buy Now Access Full
Report:- https://www.databridgemarketresearch.com/reports/saudi-arabia-osteoporosis-drug-market
Competitive
Landscape and Saudi Arabia Osteoporosis Drugs Market Share Analysis
Browse The Table of Contents And List of Figures: https://www.databridgemarketresearch.com/toc/?dbmr=saudi-arabia-osteoporosis-drug-market
Major TOC of the Saudi
Arabia Osteoporosis Drugs Market Report
Chapter One:
MARKET SEGEMENTATION
EXECUTIVE SUMMARY
PREMIUM INSIGHTS
MARKET OVERVIEW
Saudi Arabia Osteoporosis
Drugs Market Scope
The osteoporosis drugs market is categorized into
eight notable segments based on type, drugs, drugs type, route of
administration, gender, age group, end user, and distribution channel. The
growth amongst these segments will help you analyze meager growth segments in
the industries and provide the users with a valuable market overview and market
insights to help them make strategic decisions for identifying core market
applications.
Type
· Primary
Osteoporosis
· Secondary
Osteoporosis.
On the basis of type, Saudi Arabia osteoporosis
drugs market is segmented into primary osteoporosis and secondary osteoporosis.
Drugs
· Bisphosphonates
· Monoclonal
Antibodies
· Hormone Therapy
· Others
On the basis of drugs, Saudi Arabia osteoporosis
drugs market is segmented into bisphosphonates, monoclonal antibodies, hormone
therapy and others.
Drugs Type
· Branded
· Generic
On the basis of drugs type, Saudi Arabia
osteoporosis drugs market is segmented into branded and generic.
Route of Administration
· Injectable
· Oral
· Others
On the basis of route of administration, Saudi
Arabia osteoporosis drugs market is segmented into injectable, oral and others.
Gender
· Female
· Male
On the basis of gender, Saudi Arabia osteoporosis
drugs market is segmented into female and male.
Age Group
· Geriatrics
· Adults
· Pediatrics
On the basis of age group, Saudi Arabia
osteoporosis drugs market is segmented into geriatrics, adults and pediatrics.
End User
· Hospitals
· Specialty Clinics
· Homecare
· Others
On the basis of end user, Saudi Arabia osteoporosis
drugs market is segmented into hospitals, specialty clinics, homecare and
others.
Distribution Channel
· Direct Tender
· Retail Sales
· Others
On the basis of distribution channel, Saudi Arabia
osteoporosis drugs market is segmented into direct tender, retail sales and
others.
Competitive Landscape
and Osteoporosis Drugs Market Share Analysis
Details included are company overview, company
financials, revenue generated, market potential, investment in research and
development, new market initiatives, Saudi Arabia presence, production sites
and facilities, production capacities, company strengths and weaknesses,
product launch, product width and breadth, application dominance. The above
data points provided are only related to the companies' focus related to
osteoporosis durgs market.
Some of the major
players operating in the Saudi Arabia osteoporosis drugs market are
·
Eli Lilly and Company,
·
Novartis AG,
·
Amgen Inc.,
·
Tabuk pharmaceuticals,
·
SPIMACO,
·
Hikma Pharmaceuticals PLC,
·
Pfizer Inc.,
·
Merck KGaA, Apotex Inc.,
·
ABIOGEN PHARMA S.p.A.,
·
Sudair Pharma,
·
tadawipharma.,
·
Fresenius SE & Co. KGaA,
·
Hayat Pharmaceutical Industries Co. PLC,
· and SAJA
Pharmaceuticals among others.
About Us:
Data Bridge Market Research set
forth itself as an unconventional and neoteric Market research and consulting
firm with unparalleled level of resilience and integrated approaches. We are
determined to unearth the best market opportunities and foster efficient
information for your business to thrive in the market
Contact:
Data Bridge Market
Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Browse Related
Reports@
North America Dental Diagnostic and Surgical Equipment Market
Europe Dental Diagnostic and Surgical Equipment Market
Global Dental Diagnostic and Surgical Equipment Market
Middle East and Africa Refractories Market
Comments
Post a Comment